| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $285.7M | -21.4% |
| Cost of Revenue | $984K | -68.3% |
| R&D Expense | $176.6M | -4.7% |
| SG&A Expense | $176.3M | -23.6% |
| Operating Income | -$68.2M | -22.5% |
| Interest Expense | $21.4M | -60.7% |
| Pre-tax Income | -$174.9M | -91.3% |
| Net Income | $221.8M | +342.6% |
| EPS (Basic) | $6.56 | +328.6% |
| EPS (Diluted) | $6.56 | +328.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.5M | -40.4% |
| Accounts Receivable | $26.9M | -43.6% |
| Inventory | $6.5M | -25.0% |
| Current Assets | $540.1M | +7.5% |
| Total Assets | $553.7M | +5.1% |
| Current Liabilities | $230.1M | +37.9% |
| Long-term Debt | $223.1M | -58.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.8M | +35.7% |
| Capital Expenditures | $568K | +43.1% |
| Investing Cash Flow | $261.8M | +270.2% |
| Financing Cash Flow | -$267.3M | — |
| Free Cash Flow | -$27.3M | +34.9% |
| Total Liabilities |
| $460.6M |
| -35.2% |
| Stockholders' Equity | $93.1M | +150.6% |